In a lengthy public statement issued by the Food and Drug Administration (FDA) on July 9, Commissioner Scott Gottlieb pledged: “While we work to ensure appropriate and rational prescribing of opioids, we won’t lose sight of the needs of Americans living with serious chronic pain or coping with pain at the end of life. They, too, face significant challenges.
Eight senators submitted a letter to Attorney General Sessions Sessions regarding the status of 26 open applications to manufacture marijuana for research purposes.
APS President Dr. William Maixner and APS Board Member Dr. John Markman speak to NPR on how to talk to your doctor about pain.
A recent study found that patients who were educated on the neuroscience of pain and persisted in challenging physical therapy despite their chronic pain had better mental and physical health, and less disability than the standard treatment. The researchers conclude that staying active despite the pain can result in overall better health – including the pain itself.
APS Director-at-Large, Dr. Mark Wallace, appears in an article that reports on the positive impact of medical marijuana use among seniors.
The Alan Edwards Fellowship in Clinical Pain Research is a training opportunity for health care professionals already possessing an MD or PhD who are interested in pursuing original clinical research in the field of pain medicine with the team at the AEPMU.
This article explores the recent history of basic and clinical research into the neuroscience of acute and chronic pain. Human volunteers and functional MRI are particularly emphasized.
The American Pain Society today announced its selections of clinical psychologist Tonya Palermo, Ph.D. as Treasurer and three new members of the Board of Directors: John Markman, M.D., Jamie Rhudy, Ph.D. and David Tauben, M.D.
New research, published this month by the American Pain Society (APS), adds to burgeoning scientific evidence showing that interdisciplinary pain rehabilitation programs are an effective alternative to opioids for chronic pain management.
A recent study in rats found that morphine treatment after laparotomy prolonged pain and hypersensitivity after the surgery, with longer opioid treatment correlated with longer pain duration. This prolongation of chronic pain could be due to inflammation in the central nervous system caused by the opioid treatment.
Research institutions in the U.S. received more than $2.3 billion for basic science research in 2017 from foundations, philanthropists, corporations, and charities, according to the Private Funding of Basic Science Survey conducted by the Science Philanthropy Alliance. The top ten institutions received 65% of this amount.
Read the Director's Message from Dr. Walter Koroshetz, Director of NINDS, and the JAMA Viewpoint to get a better understanding of the HEAL initiative.
The Foundation is interested in fresh approaches to solving common, everyday problems or emerging issues within our defined focus area. Projects should focus on issues faced by care providers that, when implemented, will improve the health, nutrition and/or developmental outcomes for infants and young children. The board is particularly looking for practical solutions that can be easily and rapidly implemented on a broad scale with a predictable time frame to clinical application.
As part of the agency's ongoing commitment to address the epidemic of opioid misuse and abuse, the U.S. Food and Drug Administration today launched an innovation challenge to spur the development of medical devices, including digital health technologies and diagnostic tests that could provide novel solutions to detecting, treating and preventing addiction, addressing diversion and treating pain.
Christopher Jones, a captain in the Commissioned Corps, tells of his struggle with addiction and his story of recovery to give hope to others.
William Maixner, DDS PhD, gave an update from the American Pain Society at the 13th Annual Pain Consortium Symposium on June 1. View the presentation.
Treatments that target only specific cell types may potentially relieve chronic pain from neuroinflammation while avoiding the side effects of systemic drugs.
On May 30-31, 2018, the inaugural meeting of the Pain Management Task Force will feature speakers from HHS, VA, DoD, ONDCP as well as perspectives on pain management from experts in the field.